Literature DB >> 23174357

Esthesioneuroblastoma.

Thomas J Ow1, Diana Bell, Michael E Kupferman, Franco Demonte, Ehab Y Hanna.   

Abstract

Esthesioneuroblastoma is a rare malignant neoplasm in the olfactory region of the nasal cavity and anterior skull base. Diagnosis and staging require anatomic imaging and careful pathologic assessment. Standard treatment is anterior craniofacial resection with postoperative irradiation. The role for chemotherapy is not defined, but is generally for the most advanced cases and used in the neoadjuvant setting and/or postoperatively with irradiation. Prognosis is favorable; however, metastasis rates remain relatively high. Regional and distant metastasis portends a poor outcome. Intensity-modulated radiation treatment and endoscopic surgery have reduced morbidity, but outcomes with these techniques must be fully evaluated.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23174357     DOI: 10.1016/j.nec.2012.08.005

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  25 in total

1.  Olfactory Neuroblastoma: A Case Report.

Authors:  Heather R Olmo; Steven Marc Stokes; Robert D Foss
Journal:  Head Neck Pathol       Date:  2015-08-28

Review 2.  Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system.

Authors:  Rami E Saade; Ehab Y Hanna; Diana Bell
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

3.  Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma.

Authors:  Justin G Peacock; William S Harmsen; Michael J Link; Jamie J Van Gompel; Caterina Giannini; Kerry D Olsen; Yolanda I Garces; Michelle A Neben Wittich; Daniel J Ma; Sean S Park; Robert L Foote
Journal:  J Neurol Surg B Skull Base       Date:  2016-07-06

4.  Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.

Authors:  Diana Bell; Rami Saade; Dianna Roberts; Thomas J Ow; Michael Kupferman; Franco DeMonte; Ehab Y Hanna
Journal:  Head Neck Pathol       Date:  2014-05-08

Review 5.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

6.  Sinonasal Carcinomas with Neuroendocrine Features: Histopathological Differentiation and Treatment Outcomes.

Authors:  Liuba Soldatova; Raewyn G Campbell; Ricardo L Carrau; Daniel M Prevedello; Paul Wakely; Bradley A Otto; Leo F Ditzel Filho
Journal:  J Neurol Surg B Skull Base       Date:  2016-04-26

Review 7.  Olfactory Neuroblastoma.

Authors:  Ahmed S Abdelmeguid
Journal:  Curr Oncol Rep       Date:  2018-02-07       Impact factor: 5.075

8.  Idiopathic SIADH in young patients: don't forget the nose.

Authors:  C Parrilla; D Lucidi; G Petrone; G Bastanza; C Colosimo
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-02       Impact factor: 2.124

9.  Changing Trends in the Management of Esthesioneuroblastoma: Irish and International Perspectives.

Authors:  Robbie S R Woods; Thavakumar Subramaniam; Mary Leader; Rory McConn-Walsh; James Paul O'Neill; Peter D Lacy
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-01

10.  Surgical management of skull base tumors.

Authors:  Leonardo Rangel-Castilla; Jonathan J Russin; Robert F Spetzler
Journal:  Rep Pract Oncol Radiother       Date:  2014-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.